tiprankstipranks
Advertisement
Advertisement

TKPHF Stock Latest News

Takeda announces publication of data from Phase 3 studies of oveporexton
The FlyTakeda announces publication of data from Phase 3 studies of oveporexton
4d ago
TAK
Protagonist Therapeutics announces $300M share repurchase program
PremiumThe Fly
Protagonist Therapeutics announces $300M share repurchase program
4d ago
JNJ
TAK
Keros Therapeutics announces $5M share repurchase program after Takeda payment
PremiumThe Fly
Keros Therapeutics announces $5M share repurchase program after Takeda payment
4d ago
TAK
KROS
Trump Trade: President warns communities against rejecting data centers
PremiumThe Fly
Trump Trade: President warns communities against rejecting data centers
12d ago
AZN
LLY
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
PremiumThe Fly
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
12d ago
TAK
PTGX
Bayer, Takeda expected to announce new pricing deals with White House, FT says
PremiumThe FlyBayer, Takeda expected to announce new pricing deals with White House, FT says
12d ago
AZN
LLY
Protagonist Therapeutics price target raised to $170 from $167 at H.C. Wainwright
Premium
The Fly
Protagonist Therapeutics price target raised to $170 from $167 at H.C. Wainwright
13d ago
TAK
PTGX
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
Premium
The Fly
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
13d ago
TAK
PTGX
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
PremiumCompany Announcements
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
15d ago
Takeda receives FDA approval of NDA for Mimrylo
PremiumThe Fly
Takeda receives FDA approval of NDA for Mimrylo
15d ago
TAK
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
PremiumThe Fly
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
16d ago
SNY
TAK
Takeda announces Japan MHLW approval for Orzeyful
PremiumThe Fly
Takeda announces Japan MHLW approval for Orzeyful
20d ago
TAK
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
PremiumRatingsAnalyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
1M ago
TAK
Takeda award from Veterans Affairs posted to SAM.gov site
Premium
The Fly
Takeda award from Veterans Affairs posted to SAM.gov site
1M ago
TAK
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
Premium
Company Announcements
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
1M ago
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1
PremiumThe Fly
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1
1M ago
TAK
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1 in adults
PremiumThe Fly
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1 in adults
1M ago
TAK
Keros Therapeutics to receive $20M elritercept milestone payment from Takeda
PremiumThe Fly
Keros Therapeutics to receive $20M elritercept milestone payment from Takeda
1M ago
TAK
KROS
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
PremiumRatings
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
1M ago
TAK
Takeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline
PremiumCompany AnnouncementsTakeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline
1M ago
Takeda dengue vaccine receives marketing authorization from India DCGI
Premium
The Fly
Takeda dengue vaccine receives marketing authorization from India DCGI
2M ago
TAK
Takeda, the Indoensian Government announce collaboration
Premium
The Fly
Takeda, the Indoensian Government announce collaboration
2M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >